Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - CASH & EQUIVALENTS
Cash & Equivalents REGN - Regeneron Pharmaceuticals, Inc.
2.49 B
LAST VALUE
-10.49%
2 YEAR CAGR
8.99%
5 YEAR CAGR
14.39%
10 YEAR CAGR